Compare Stocks → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AMYTCVE:BMKCVE:ICCCVE:NXS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMYTAmryt Pharma$14.70+0.1%$14.64$6.41▼$14.77$940.21M0.84757,360 shs2.39 million shsBMKMacDonald Mines ExplorationC$0.05-9.1%C$0.05C$0.03▼C$0.09C$1.89M0.4861,967 shs103,430 shsICCICC LabsC$1.62-5.8%C$1.62C$0.87▼C$2.00C$223.64MN/A799,310 shs646,156 shsNXSNexus GoldC$0.02-20.0%C$0.02C$0.02▼C$0.10C$837K0.7463,040 shs6,000 shs5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMYTAmryt Pharma0.00%0.00%0.00%0.00%+0.82%BMKMacDonald Mines Exploration-9.09%0.00%0.00%-16.67%-28.57%ICCICC Labs0.00%0.00%0.00%0.00%0.00%NXSNexus Gold0.00%0.00%+33.33%0.00%+100.00%Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMYTAmryt PharmaN/AN/AN/AN/AN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AN/AN/AN/AICCICC LabsN/AN/AN/AN/AN/AN/AN/AN/ANXSNexus GoldN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMYTAmryt PharmaN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AICCICC LabsN/AN/AN/AN/ANXSNexus GoldN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMYTAmryt Pharma$222.54M4.22$0.98 per share14.98$5.58 per share2.63BMKMacDonald Mines ExplorationC$-74K-25.59C$0.00 per share13.00C($0.01) per share-5.00ICCICC LabsC$533.68K419.04C$0.06 per share28.42C$0.29 per share5.68NXSNexus GoldN/AN/AC$0.00 per share10.00C($0.01) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMYTAmryt Pharma$1M-$0.06N/A735.00N/A-8.19%1.70%0.75%N/ABMKMacDonald Mines Exploration-C$1.28M-C$0.02N/A∞N/AN/A-1,679.48%-324.12%5/6/2024 (Estimated)ICCICC LabsN/AC$0.0295.29∞N/AN/AN/AN/AN/ANXSNexus Gold-C$1.92M-C$0.06N/A∞N/AN/A-1,307.50%-53.77%5/29/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMYTAmryt PharmaN/AN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AICCICC LabsN/AN/AN/AN/AN/ANXSNexus GoldN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMYTAmryt Pharma0.641.570.94BMKMacDonald Mines Exploration3.840.220.27ICCICC LabsN/A24.848.74NXSNexus Gold14,120.330.050.38OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMYTAmryt Pharma71.31%BMKMacDonald Mines Exploration1.10%ICCICC LabsN/ANXSNexus GoldN/AInsider OwnershipCompanyInsider OwnershipAMYTAmryt Pharma5.66%BMKMacDonald Mines Exploration8.53%ICCICC LabsN/ANXSNexus Gold0.51%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMYTAmryt Pharma2,02063.96 million60.34 millionNot OptionableBMKMacDonald Mines Exploration237.88 millionN/ANot OptionableICCICC LabsN/A138.05 millionN/ANot OptionableNXSNexus GoldN/A41.87 millionN/ANot OptionableICC, NXS, BMK, and AMYT HeadlinesSourceHeadline'Stellaris Nexus' Is Now Called 'Nexus 5X' And Gets April Release Date - Trailerworthplaying.com - March 21 at 7:20 PMWeb3 Gaming Company Saltwater Raises $5.5M Seed Fundingmarkets.businessinsider.com - February 1 at 10:47 AMNexus Gold Provides Update on Public Listing of Nexus Metalsgoldseiten.de - January 30 at 5:12 PMNexus G1 Blackmagic box camera project creates controversyredsharknews.com - January 12 at 7:15 AMThe Nexus G1. A Box Camera Mod Using the Blackmagic Design Pocket 6K G1newsshooter.com - January 6 at 6:40 PMExcision Adds Nexus Tour Dates to Kia Forum — Here’s How To Get Presale Code Ticketsgrimygoods.com - December 13 at 7:37 PMNexus Gold Corp Class Amorningstar.com - December 7 at 8:17 PMNexus Gold and Belgravia Hartford Jointly Announce Revised Debt Settlement Transactionfinance.yahoo.com - November 22 at 6:31 PMClosing Bell: Nexus Gold Corp down on Monday (NXS)theglobeandmail.com - November 15 at 7:27 PMAll You Need To Know About ‘Nexus One’ Mobile App Launched By Navi Mumbai's Nexus Seawoods Mallmsn.com - November 6 at 8:50 AMHow Does Nexus Blitz Work In LOL?msn.com - October 30 at 3:50 AMClosing Bell: Nexus Gold Corp down on Thursday (NXS)theglobeandmail.com - October 20 at 8:46 PMClosing Bell: Nexus Gold Corp up on Friday (NXS)theglobeandmail.com - October 14 at 9:59 AMClosing Bell: Nexus Gold Corp up on Monday (NXS)theglobeandmail.com - October 3 at 1:24 AMBELGRAVIA HARTFORD Announces 13% Ownership in Nexus Gold and a 13% Ownership for Pennsylvania Hawthornefinance.yahoo.com - August 30 at 7:01 AMNexus Gold Announces Debt Settlementgoldseiten.de - August 28 at 8:26 PMClosing Bell: Nexus Gold Corp flat on Tuesday (NXS)theglobeandmail.com - August 3 at 6:32 PMClosing Bell: Nexus Gold Corp up on Thursday (NXS)theglobeandmail.com - August 3 at 6:32 PMClosing Bell: Nexus Gold Corp flat on Friday (NXS)theglobeandmail.com - July 15 at 9:06 AMNexus Gold Provides Update on Private Placementgoldseiten.de - June 30 at 6:50 PMNexus Gold Options Fofora Gold Project, Hounde Greenstone Belt, Burkina Fasojuniorminingnetwork.com - June 7 at 3:32 PMNexus Gold Closes First Tranche of $1 Million Private Placement and Files Amended and Restated Offering Documentgoldseiten.de - May 30 at 2:50 PMNexus Gold announces share consolidationseekingalpha.com - May 16 at 3:52 PMClosing Bell: Nexus Gold Corp flat on Wednesday (NXS)theglobeandmail.com - May 4 at 4:22 AMMedia Sentiment Over TimeCompany DescriptionsAmryt PharmaNASDAQ:AMYTAmryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.MacDonald Mines ExplorationCVE:BMKMacDonald Mines Exploration Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold, silver, copper, cobalt, and nickel deposits. It owns 100% interest in the Scadding-Powerline-Jovan property that covers an area of 19,710 hectares located to the east of Sudbury in Northern Ontario. The company was formerly known as MacDonald Mines Limited. MacDonald Mines Exploration Ltd. was incorporated in 1936 and is based in Toronto, Canada.ICC LabsCVE:ICCICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.Nexus GoldCVE:NXSNexus Gold Corp. engages in the exploration and evaluation of mineral properties in West Africa and Canada. The company explores for gold, silver, manganese, bauxite, copper, nickel, lead, zinc, and limestone/marble deposits. Its flagship property is the Bouboulou project located in Burkina Faso, West Africa. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.